Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Surgical Endoscopy
Published in: Surgical Endoscopy 2/2009

01-02-2009 | Endoluminal

The Plicator procedure for the treatment of gastroesophageal reflux disease: a registry study

Authors: John Birk, Ronald Pruitt, Gregory Haber, Isaac Raijman, Arthur Baluyut, Mick Meiselman, Shahriar Sedghi

Published in: Surgical Endoscopy | Issue 2/2009

Login to get access

Abstract

Background

Endoscopic full-thickness plication of the gastric cardia using the Plicator is shown to be effective for the treatment of symptomatic gastroesophageal reflux disease (GERD) in both prospective and randomized controlled trials. This registry study aimed to evaluate Plicator procedure safety and efficacy among GERD patients treated in routine clinical practice at multiple academic and nonacademic centers.

Methods

An open-label, prospective multicenter trial was conducted at seven centers under institutional review board approval. Patients with symptomatic GERD completed a series of questionnaires at baseline to assess GERD symptoms, heartburn/regurgitation scores, antisecretory medication use, and treatment satisfaction. All the patients then underwent the Plicator procedure with placement of a single transmural pledgeted suture in the anterior gastric cardia. The patients were reevaluated at 12 months after plication.

Results

The 12-month follow-up assessment was completed by 81 patients. At 12 months, the mean GERD Health-Related Quality-of-Life score had improved significantly compared with the baseline score (12.0 vs 26.6; p < 0.001), with 66% of the subjects showing an GERD-HRQL score improved 50% or more. Statistically significant improvements also were observed in median heartburn and regurgitation symptom scores. At 12 months, the need for daily proton pump inhibitor (PPI) therapy was eliminated for 58% of the patients. At baseline, 18% of the subjects had been satisfied with their GERD symptom control while on antisecretory therapy. At 12 months, 75% of the patients were satisfied with their GERD symptom control after undergoing the Plicator procedure, and 86% would recommend the procedure to family or friends. There were no serious adverse events and no late onset of any adverse events.

Conclusions

In this multicenter study, the Plicator procedure effectively improved GERD quality-of-life scores, reduced GERD symptoms and medication use, and yielded higher treatment satisfaction than with the use of chronic antisecretory therapy. These effects all were seen 12 months after plication, and no major adverse effects were observed.
Literature
1.
Dean BB, Crawley JA, Schmitt CM, Wong J, Ofman JJ (2003) The burden of illness of gastro-oesophageal reflux disease: impact on work productivity. Aliment Pharmacol Ther 17:1309–1317PubMedCrossRef
2.
Frank L, Kleinman L, Ganoczy D, McQuaid K, Sloan S, Eggleston A, Tougas G, Farup C (2000) Upper gastrointestinal symptoms in North America: prevalence and relationship to healthcare utilization and quality of life. Dig Dis Sci 45:809–818PubMedCrossRef
3.
Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R (2002) The burden of selected digestive diseases in the United States. Gastroenterology 122:1500–1511PubMedCrossRef
4.
Fass R, Ofman JJ (2002) Gastroesophageal reflux disease: should we adopt a new conceptual framework? Am J Gastroenterol 97:1901–1909PubMed
5.
Poelmans J, Tack J (2005) Extraoesophageal manifestations of gastro-oesophageal reflux. Gut 54:1492–1499PubMedCrossRef
6.
Ruigomez A, Garcia Rodriguez LA, Wallander MA, Johansson S, Graffner H, Dent J (2004) Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther 20:751–760PubMedCrossRef
7.
Wiklund I (2004) Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis 22:108–114PubMedCrossRef
8.
Dent J, El-Serag HB, Wallander MA, Johansson S (2005) Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 54:710–717PubMedCrossRef
9.
Lagergren J, Bergstrom R, Lindgren A, Nyren O (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. New Engl J Med 340:825–831PubMedCrossRef
10.
Joish VN, Donaldson G, Stockdale W, Ordera GM, Crawley J, Sasane R, Joshua-Gotlib S, Brixner DI (2005) The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database. Curr Med Res Opin 21:535–544PubMedCrossRef
11.
Lauritsen K, Deviere J, Bigard MA, Bayerdorffer E, Mozsik G, Murray F, Kristjansdottir S, Savarino V, Vetvik K, DeFreitas D, Orive V, Rodrigo L, Fried M, Morris J, Schneider H, Eklund S, Larko A (2003) Esopmeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: metropole study results. Ailment Pharmacol Ther 17:333–341CrossRef
12.
Klinkenberg-Knol EC, Nelis F, Dent J, Snel P, Mitchell B, Prichard P, Lloyd D, Havu N, Frame MH, Roman J, Walan A (2000) Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology 118:661–669PubMedCrossRef
13.
Leite LP, Johnston BT, Just RJ, Castell DO (1996) Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol 91:1527–1531PubMed
14.
Chiba N, De Gara CJ, Wilkinson JM, Hunt RH (1997) Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 112:1798–1810PubMedCrossRef
15.
Lafullarde T, Watson DI, Jamieson GG, Myers JC, Game PA, Devitt PG (2001) Laparoscopic Nissen fundoplications: five-year results and beyond. Arch Surg 136:180–184PubMedCrossRef
16.
Gotley DC, Smithers BM, Rhodes M, Menzies B, Branicki FJ, Nathanson L (1996) Laparoscopic Nissen fundoplication: 200 consecutive cases. Gut 38:487–491PubMedCrossRef
17.
Hunter JG, Trus TL, Branum GD, Waring JP, Wood WC (1996) A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg 223:673–685PubMedCrossRef
18.
Rantanen TK, Salo JA, Sipponen JT (1999) Fatal and life-threatening complications in antireflux surgery: analysis of 5,502 operations. Br J Surg 86:1573–1577PubMedCrossRef
19.
Swanstrom L, Wayne R (1994) Spectrum of gastrointestinal symptoms after laparoscopic fundoplication. Am J Surg 167:538–541PubMedCrossRef
20.
Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, Raufman JP, Sampliner R, Schnell T, Sontag S, Vlahcevic ZR, Young R, Williford W (2001) Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 285:2331–2338PubMedCrossRef
21.
Freston JW, Triadofilopoulos G (2004) Review article: approaches to the long-term management of adults with GERD-proton pump inhibitor therapy, laparoscopic fundoplication, or endoscopic therapy? Aliment Pharmacol Ther 19(Suppl 1):35–42PubMedCrossRef
22.
Corley DA, Katz P, Wo JM, Stefan A, Patti M, Rothstein R, Edmundowicz S, Kline M, Mason R, Wolfe MM (2003) Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology 125:668–676PubMedCrossRef
23.
Schwartz MP, Wellink H, Gooszen HG, Conchillo JM, Samsom M, Smout A (2007) Endoscopic gastroplication for the treatment of gastro-oesophageal reflux disease: a randomised, sham-controlled trial. Gut 56:20–28PubMedCrossRef
24.
Deviere J, Costamagna G, Neuhaus H, Voderholzer W, Louis H, Tringali A, Marchese M, Fiedler T, Darb-Esfahani P, Schumacher B (2005) Nonresorbable copolymer implantation for gastroesophageal reflux disease: a randomized sham-controlled multicenter trial. Gastroenterology 128:532–540PubMedCrossRef
25.
Cadiere GB, Rajan A, Germay O, Jimpens J (2007) Endoluminal fundoplication by a transoral device for the treatment of GERD: a feasibility study. Surg Endosc 10.​1007/​s00464-007-9618-9
26.
Pleskow D, Rothstein R, Lo S, Hawes R, Kozarek R, Haber G, Gostout C, Lembo A (2004) Endoscopic full-thickness plication for the treatment of GERD: a multicenter trial. Gastrointest Endosc 59:163–171PubMedCrossRef
27.
Pleskow D, Rothstein R, Lo S, Hawes R, Kozarek R, Haber G, Gostout C, Lembo A (2005) Endoscopic full-thickness plication for GERD: 12-month follow-up for the North American open-label trial. Gastrointest Endosc 61:643–649PubMedCrossRef
28.
Rothstein R, Filipi C, Caca K, Pruitt R, Mergener K, Torquati A, Haber G, Chen Y, Chang K, Wong D, Deviere J, Pleskow D, Lightdale C, Ades A, Kozarek R, Richards W, Lembo A (2006) Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease: a randomized, sham-controlled trial. Gastroenterology 131:704–712PubMedCrossRef
29.
Pleskow D, Rothstein R, Kozarek R, Haber G, Gostout C, Lembo A (2006) Endoscopic full-thickness plication for the treatment of GERD: long-term multicenter results. Surg Endosc 21:439–444PubMedCrossRef
30.
Pleskow D, Rothstein R, Kozarek R, Haber G, Gostout C, Lo S, Hawes R, Lembo A (2007) Endoscopic full-thickness plication for the treatment of GERD: five-year long-term multicenter results. Surg Endosc 10.​1007/​s00464-007-9667-0
31.
Pleskow D, Rothstein R, Kozarek R, Haber G, Gostout C, Lo S, Hawes R, Lembo A (2008) Endoscopic full-thickness plication for the treatment of GERD: five-year long-term multicenter results. Surg Endosc 22:326–332; Epub 2007 NovemberPubMedCrossRef
32.
Velanovich V, Vallance SR, Gusz JR, Tapia FV, Harkabus MA (1996) Quality-of-life scale for gastroesophageal reflux disease. J Am Coll Surg 183:217–224PubMed
33.
Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, Raufman JP, Sampliner R, Schnell T, Sontag S, Vlahcevic R, Young R, Williford W (2001) Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 285:2331–2338PubMedCrossRef
Metadata
Title
The Plicator procedure for the treatment of gastroesophageal reflux disease: a registry study
Authors
John Birk
Ronald Pruitt
Gregory Haber
Isaac Raijman
Arthur Baluyut
Mick Meiselman
Shahriar Sedghi
Publication date
01-02-2009
Publisher
Springer-Verlag
Published in
Surgical Endoscopy / Issue 2/2009
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-008-0109-4

Other articles of this Issue 2/2009

Surgical Endoscopy 2/2009 Go to the issue

OriginalPaper

Adhesion formation of a polyvinylidenfluoride/polypropylene mesh for intra-abdominal placement in a rodent animal model

OriginalPaper

Quantification of eccrine sweat glands with acetylcholine sweat-spot test and anatomical redistribution of sweating after T2–T3 thoracoscopic sympathicolysis

OriginalPaper

Influence of thoracic epidural analgesia on postoperative pain relief and ileus after laparoscopic colorectal resection

OriginalPaper

Laparoscopy influences hiring practices within academic surgical departments

OriginalPaper

Laparoscopic splenectomy for blunt trauma: a safe operation following embolization

OriginalPaper

Peroral transgastric endoscopic procedures in pigs: feasibility, survival, questionings, and pitfalls